Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
AstraZeneca (Not applicable)
- License Information
-
More Information
Article History
First Online: 8 January 2020
Compliance with Ethical Standards
:
: This article was funded by AstraZeneca, Cambridge, UK, the manufacturers of osimertinib.
: The authors and reviewers of this article are all employees of AstraZeneca. The work described herein was completed as a routine operational activity within the remit of their regular employment. No specific financial or other such incentives were received for conducting this work.
